SALIX PHARMACEUTICALS LTD DEL (SLXP1)

Sector:
HEALTH CARE
Industry:
HEALTH CARE
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Carolyn J. Logan
Employees:
1,000
8510 COLONNADE CENTER DRIVE, RALEIGH, NC 27615
(919) 862-1000

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Salix Pharmaceuticals, Ltd. acquires, develops, and commercializes prescription drugs and medical devices to treat various gastrointestinal diseases in the United States.

Data derived from most recent annual or quarterly report
Market Cap 0 Shares Outstanding0 Avg 30-day Volume 4.172 Million
P/E Ratio45.167 Dividend Yield0.0 EPS-6.53
Price to Revenue6.4658 Debt to Equity2.2517 EBITDA343.788 Million
Price to Book Value8.1087 Operating Margin27.6118 Enterprise Value5.641 Billion
Current Ratio5.471 EPS Growth0.97 Quick Ratio3.095
1 Yr BETA 0.9946 52-week High/Low 0.0 / Profit Margin14.3154
Operating Cash Flow Growth374.7637 Altman Z-Score3.006 Free Cash Flow to Firm 384.452 Million
View SEC Filings from SLXP1 instead.

View recent insider trading info

Funds Holding SLXP1 (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding SLXP1 BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

CHAPPELL JOHN F

  • Director
No longer subject to file 2015-04-01 0

CREECH TIMOTHY J SEE REMARKS

  • Officer
No longer subject to file 2015-04-01 0

KEANE WILLIAM P

  • Director
No longer subject to file 2015-04-01 0

D ALONZO THOMAS ACTING PRESIDENT AND CEO

  • Officer
  • Director
No longer subject to file 2015-04-01 0

BERTRAND WILLIAM C JR SEE REMARKS

  • Officer
No longer subject to file 2015-04-01 0

SIRGO MARK A

  • Director
No longer subject to file 2015-04-01 0

FORBES WILLIAM P PRESIDENT, MEDICAL, R&D & CDO

  • Officer
No longer subject to file 2015-04-01 0

SCRUGGS RICK D EXECUTIVE VICE PRESIDENT

  • Officer
No longer subject to file 2015-04-01 0

LOGAN CAROLYN J PRESIDENT & CEO

  • Officer
  • Director
1,103,838 2014-12-22 0

DERBYSHIRE ADAM C EVP FINANCE/CFO

  • Officer
218,463 2014-08-22 0

REETH MARK D GEN COUNSEL&VP CORP COMPLIANCE

  • Officer
33,668 2012-05-01 0

FRANCO RICHARD A

  • Director
72,968 2012-04-05 0

FLYNN JAMES E

DEERFIELD CAPITAL LP

DEERFIELD PARTNERS, LP

DEERFIELD MANAGEMENT CO /NY

DEERFIELD INTERNATIONAL LTD

  • 10% Owner
  • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
No longer subject to file 2009-09-08 0

FLYNN JAMES E

DEERFIELD MANAGEMENT CO /NY

DEERFIELD INTERNATIONAL LTD

  • 10% Owner
  • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
6,435,953 2009-08-18 0

HARRAL WILLIAM III

  • Director
67,289 2008-07-01 0

TAYLOR DAVID N MD VP - CHIEF MEDICAL OFFICER

  • Officer
124,000 2006-07-13 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments